Brimochol PF is a preservative-free combination drop containing carbachol and brimonidine. Both of these miosis-inducing medications are combined to enhance the range of vision by producing a ...

Researchers saw a greater reduction in LDL-C, as well as all-cause mortality, major adverse CV events, and stroke incidence in patients using combination lipid-lowering therapy. HealthDay News — ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

The single combination drop formulation significantly simplifies treatment regimens, addressing a major challenge in glaucoma management—patient adherence. By combining two medications into one ...

A greater reduction LDL-C was seen for combo therapy; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence. HealthDay News — Combination lipid-lowering therapy ...

The researchers found that compared with statin monotherapy, combination LLT significantly more effectively reduced the LDL-C level from baseline in a pooled analysis (mean difference, –12.96 mg ...